Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-004800

Head of Pharm Ops and Tech gave up 761 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 2,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2024-02-09 Option exercise +2,272 9,528.99 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2024-02-09 Shares withheld for taxes −761 $240.98 $183,386 8,767.99 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2024-02-09 Option exercise · Restricted Stock Unit −2,272 2,272 D: show line 3 in the form
Loading xslF345X05/form4.xml…